)
Visual
earnings real time
Pulse Biosciences (PLSE) investor relations material
Pulse Biosciences Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Piper Sandler 37th Annual Healthcare Conference summary3 Dec, 2025
Technology overview and differentiation
Nanosecond PFA delivers ultra-short, high-amplitude pulses with less overall energy, enabling disruptive therapies for large unmet clinical needs.
The platform is protected by 215 issued patents (up 35 in the past year) and 100 pending, providing a strong proprietary moat.
Mechanism of action is non-thermal, causing regulated cell death without damaging nerves or blood vessels, and allows for repeated ablation without temperature rise.
Enables procedures without general anesthesia, moving treatments closer to outpatient settings and increasing system flexibility.
Supported by over 1,000 publications, with dozens specific to the company, and seven FDA clearances including a breakthrough device designation.
Market strategy and financials
Targeting three main markets: thyroid, cardiac surgery, and electrophysiology (EP), with a current combined value of $6 billion, expected to grow to $16 billion in the next few years.
Employs a hybrid business model: direct commercialization for low-resistance markets (e.g., thyroid) and partnerships for capital-intensive markets (e.g., EP).
Strong balance sheet with $95 million in cash at Q3 end and a projected $36 million burn for 2024, increasing with two IDEs and a commercial launch in 2025.
Revenue generation has begun and is expected to grow, with strong inside ownership.
Board led by experienced industry figures and supported by key opinion leaders and clinical experts.
Clinical progress and commercialization
Thyroid: Launched limited market release for minimally invasive, thyroid-sparing ablation, targeting 250,000 new benign cases annually; strong early uptake and ongoing post-market studies.
Cardiac surgery: IDE underway for AFib ablation during open heart surgery, with published European feasibility data and rapid lesion creation (2.5 seconds per lesion).
EP: Filed for IDE, expecting first patient enrollment soon; ablation times as low as five seconds, total procedure times five to ten minutes, and compatibility with multiple mapping systems.
Commercialization initiated in thyroid, with plans to expand as clinical and regulatory milestones are achieved.
Pipeline includes additional therapy targets beyond current focus areas.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Pulse Biosciences earnings date
Q4 202527 Mar, 2026
Next Pulse Biosciences earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Pulse Biosciences Inc. is a medical technology company that develops therapeutic devices based on its proprietary Nano-Pulse Stimulation (NPS) technology. This technology uses short, nanosecond-duration electrical pulses to treat cellular structures, offering potential applications in dermatology, oncology, and other medical fields. Pulse Biosciences' products are designed to provide non-invasive treatment options, with the goal of improving clinical outcomes for patients in various therapeutic areas. The company is headquartered in Hayward, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage